Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NPS Pharma files Gattex NDA with FDA
The filing includes chemistry, manufacturing and controls (CMC) section of NDA for Gattex, which is indicated for the treatment of adults suffering from short bowel syndrome (SBS). Previously,
The filing includes chemistry, manufacturing and controls (CMC) section of NDA for Gattex, which is indicated for the treatment of adults suffering from short bowel syndrome (SBS). Previously,
The Trevena award includes $460,000 in direct funding, and access to millions of dollars worth of contracted research services. The NIH has awarded this contract through its Blueprint
The tie up allows the scientists of the two institutions to work together and take forward these discoveries to the next stage of research by identifying compounds that
The inspection was done by the representatives of the FDA, EMA from the Medicines and Healthcare products Regulatory Agency (MHRA) and Medical Products Agency of Sweden (MPA). As
Under an agreement signed between both the companies, Skinvisible has given Canadian marketing rights of DermSafe to Alto. Alto expects to market the product under the name DermSafePC. DermSafe
Ridaforolimus is an experimental oral mTOR inhibitor developed as a treatment for patients with metastatic soft-tissue or bone sarcomas who had a favorable response to chemotherapy. Earlier, ARIAD and
Extedo claims, the version 2.0 SP1 features new Graphical User Interface (GUI), faster automatic validation set detection, new ways to add new sequences, parallel mass validation support, improved
The prenatal test is developed utilizing the company’s bioinformatics technology – Parental Support which unites single-nucleotide polymorphism (SNP) technology with bioinformatics algorithms to produce genetic information from small
Folotyn is approved in the US as a treatment for the patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The study aims to determine the efficacy and
Sugardown is intended to help in the reduction of post-meal elevation of blood glucose. In the trial, Sugardown was evaluated in overweight healthy adults with a mean body